2,5-Dibromo-1-methyl-1H-imidazole

Catalog No. :
ACXQYW941
CAS No. :
53857-59-3
Molecular Formula :
C4H4Br2N2
Molecular Weight :
239.90

IUPAC Name:2,5-dibromo-1-methyl-1H-imidazole

2,5-Dibromo-1-methyl-1H-imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$69.00Login to see priceIn stockIn stock
5g98%$222.00Login to see priceIn stockIn stock
25g98%$1088.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5-Dibromo-1-methyl-1H-imidazole
IUPAC Name2,5-dibromo-1-methyl-1H-imidazole
MDL No.MFCD01632217
Molecular FormulaC4H4Br2N2
Molecular Weight239.90
SMILESCN1C(Br)=CN=C1Br
InChI KeyWVCRXJDDBGDCTA-UHFFFAOYSA-N
Synonym2,5-Dibromo-1-methyl-1h-imidazole | AKOS015835076 | CS-0052144 | MFCD01632217 | AB09505 | AS-54417 | 2,5-Dibromo-1-methyl-1H-imidazole, 96% | EN300-309364 | FT-0657335 | 2,5-dibromo-1-methylimidazole | 2,5-dibromo-1-methyl-imidazole | SCHEMBL15707248 | AM
CAS No.53857-59-3
PubChem CID2773360

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P280-P301+P312+P330-P302+P352-P305+P351+P338+P310

Synthetic Route by SureRoute

1. ACXQYW941 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQDSL304 route compound structure diagram
    ACQDSL30464591-03-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXQYW941 route product structure diagram
    ACXQYW94153857-59-3 In Stock
Inquiry

2. ACXQYW941 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQDSL304 route compound structure diagram
    ACQDSL30464591-03-3 In Stock
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACXQYW941 route product structure diagram
    ACXQYW94153857-59-3 In Stock
Inquiry

Comments (0)